JP2023521634A5 - - Google Patents

Info

Publication number
JP2023521634A5
JP2023521634A5 JP2022559967A JP2022559967A JP2023521634A5 JP 2023521634 A5 JP2023521634 A5 JP 2023521634A5 JP 2022559967 A JP2022559967 A JP 2022559967A JP 2022559967 A JP2022559967 A JP 2022559967A JP 2023521634 A5 JP2023521634 A5 JP 2023521634A5
Authority
JP
Japan
Prior art keywords
composition according
pharmaceutically acceptable
acceptable salt
composition
hydroxychloroquine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022559967A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023521634A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2021/050226 external-priority patent/WO2021195691A1/en
Publication of JP2023521634A publication Critical patent/JP2023521634A/ja
Publication of JP2023521634A5 publication Critical patent/JP2023521634A5/ja
Priority to JP2026060931A priority Critical patent/JP2026117029A/ja
Pending legal-status Critical Current

Links

JP2022559967A 2020-04-02 2021-03-15 炎症状態を処置または予防するための方法および組成物 Pending JP2023521634A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026060931A JP2026117029A (ja) 2020-04-02 2026-04-02 炎症状態を処置または予防するための方法および組成物

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
AU2020901030A AU2020901030A0 (en) 2020-04-02 A method of treatment
AU2020901030 2020-04-02
AU2020902432 2020-07-14
AU2020902432A AU2020902432A0 (en) 2020-07-14 A method of treatment
AU2020903985A AU2020903985A0 (en) 2020-11-02 A method of treatment
AU2020903985 2020-11-02
AU2020904264A AU2020904264A0 (en) 2020-11-18 A method of treatment
AU2020904264 2020-11-18
AU2021900241A AU2021900241A0 (en) 2021-02-03 A method of treatment
AU2021900241 2021-02-03
AU2021900324 2021-02-10
AU2021900324A AU2021900324A0 (en) 2021-02-10 A method of treatment
PCT/AU2021/050226 WO2021195691A1 (en) 2020-04-02 2021-03-15 Methods and compositions for treating or preventing an inflammatory condition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026060931A Division JP2026117029A (ja) 2020-04-02 2026-04-02 炎症状態を処置または予防するための方法および組成物

Publications (2)

Publication Number Publication Date
JP2023521634A JP2023521634A (ja) 2023-05-25
JP2023521634A5 true JP2023521634A5 (cg-RX-API-DMAC7.html) 2024-03-18

Family

ID=77926837

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022559967A Pending JP2023521634A (ja) 2020-04-02 2021-03-15 炎症状態を処置または予防するための方法および組成物
JP2026060931A Pending JP2026117029A (ja) 2020-04-02 2026-04-02 炎症状態を処置または予防するための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026060931A Pending JP2026117029A (ja) 2020-04-02 2026-04-02 炎症状態を処置または予防するための方法および組成物

Country Status (8)

Country Link
US (1) US20230128114A1 (cg-RX-API-DMAC7.html)
EP (1) EP4125835A4 (cg-RX-API-DMAC7.html)
JP (2) JP2023521634A (cg-RX-API-DMAC7.html)
AU (1) AU2021250462A1 (cg-RX-API-DMAC7.html)
CA (1) CA3169702A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022015048A2 (cg-RX-API-DMAC7.html)
IL (1) IL296943A (cg-RX-API-DMAC7.html)
WO (1) WO2021195691A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022309612A1 (en) * 2021-07-15 2024-02-01 Incannex Healthcare Limited Composition comprising cannabidiol and hydroxychloroquine in a fixed dose combination capsule
WO2024025525A1 (en) * 2022-07-27 2024-02-01 Medterra Pharma Llc Cannabinoid compositions and methods of using for the treatment of non-eosinophilic inflammation and inflammatory disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2546658A (en) 1949-07-23 1951-03-27 Sterling Drug Inc 7-chloro-4-[5-(n-ethyl-n-2-hydroxyethylamino)-2-pentyl] aminoquinoline, its acid addition salts, and method of preparation
US4160452A (en) 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US5314894A (en) 1992-09-15 1994-05-24 Sterling Winthrop Inc. (S)-(+)-hydroxychloroquine
US5453431A (en) * 1993-10-29 1995-09-26 Gilman; Andrew L. Use of hydroxychloroquine for treatment of graft-versus-host disease
GB9807639D0 (en) * 1998-04-14 1998-06-10 Kennedy Rheumatology Inst Anti-inflammatory agents
EP1450818A2 (en) * 2001-11-09 2004-09-01 Lauren Charous A method for treating inflammatory bowel disease
MXPA05001621A (es) 2002-08-14 2005-08-19 Gw Pharma Ltd Extraccion de cannabinoides farmaceuticamente activos de materiales vegetales.
US10059682B1 (en) 2016-09-30 2018-08-28 The United States Of America As Represented By The Administrator Of National Aeronautics And Space Administration Asymmetric dianhyrdrides and methods of making the same
US10189762B1 (en) 2017-07-07 2019-01-29 Orochem Technologies, Inc. Process for purification and separation of cannabinoids, from dried hemp and cannabis leaves
US20200009077A1 (en) * 2018-07-03 2020-01-09 TRUETIVA, Inc. Compositions for treating dermatological diseases
EP4106870A4 (en) * 2020-02-19 2024-04-10 Merchant, Shreema Compositions and therapeutic uses of cannabidiol

Similar Documents

Publication Publication Date Title
HRP20130052T1 (hr) Lijeäśenje respiratorne bolesti
JP2018193377A5 (cg-RX-API-DMAC7.html)
JP2023106403A5 (cg-RX-API-DMAC7.html)
US20050043321A1 (en) Method for treating atopic disorders
JP2012503668A5 (cg-RX-API-DMAC7.html)
JP2023520323A5 (cg-RX-API-DMAC7.html)
JP2010526840A5 (cg-RX-API-DMAC7.html)
CA2733294A1 (en) Pharmaceutical combination of a tiotropium salt and ciclesonide
JP2010515682A5 (cg-RX-API-DMAC7.html)
JP2023521887A5 (cg-RX-API-DMAC7.html)
Bermejo-Martin et al. Macrolides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains
JP2005523263A5 (cg-RX-API-DMAC7.html)
JP2022527401A5 (cg-RX-API-DMAC7.html)
CN115666572A (zh) 用于预防或治疗流行性rna病毒传染病的药物组合物
JP2009518415A5 (cg-RX-API-DMAC7.html)
JP2023532170A5 (cg-RX-API-DMAC7.html)
Szczeklik et al. Asthma improved by aspirin-like drugs
JP2013518061A5 (cg-RX-API-DMAC7.html)
JP2024543259A5 (cg-RX-API-DMAC7.html)
Cho et al. Lateral position prevents respiratory occlusion during surgical procedure under general anesthesia in the patient of huge anterior mediastinal lymphoblastic lymphoma
CN101057840B (zh) Vam3在制备治疗慢性阻塞性肺疾病的药物中的应用
CN116617361A (zh) 百里香酚在制备mcr-1酶抑制剂中的应用
CN106265684A (zh) 乙酰羽扇豆醇酯的应用
Kut et al. A 55-year-old man with cough and Hematochezia
CN115381843B (zh) L-岩藻糖在制备呼吸系统疾病治疗药物中的用途